Expected and unexpected effects after systemic inhibition of Hippo transcriptional output in cancer

58Citations
Citations of this article
68Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hyperactivation of YAP/TAZ, the Hippo pathway downstream effectors, is common in human cancer. In this perspective, the authors review the role of the Hippo pathway in distinct tumor cell populations, discuss the impact of inhibiting Hippo output on tumor growth, and examine current developments in YAP/TAZ inhibitors.

Cite

CITATION STYLE

APA

Baroja, I., Kyriakidis, N. C., Halder, G., & Moya, I. M. (2024). Expected and unexpected effects after systemic inhibition of Hippo transcriptional output in cancer. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-46531-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free